Document is current
Any future updates will be listed below
-
Authors
Pearlman, Ross L.
Le, Phuong B.
Brodell, Robert T.
Nahar, Vinayak K. http://orcid.org/0000-0002-6771-1662
- License Information
-
More Information
Article History
Received: 3 August 2020
Revised: 15 October 2020
Accepted: 13 November 2020
First Online: 5 January 2021
Compliance with ethical standards
:
: Robert T. Brodell discloses the following potential conflicts of interest: Multicenter Clinical Trials: Corona psoriasis biologic registry and Novartis Principal Investigator. Editorial Boards: American Medical Student Research Journal; Archives of Dermatological Research; Practice Update Dermatology; Practical Dermatology; Practical Dermatology; Journal of the Mississippi State Medical Society; SKIN: The Journal of Cutaneous Medicine; and, Journal of the American Academy of Dermatology. Advisory Boards: Bracco Diagnostics, Inc. (Gadolinium-based Contrast Agent Litigation) and Chairperson of REGN3500 AD independent monitoring committee (iDMC) (Sanofi Genzyme/Regeneron). Ross L. Pearlman, Phuong B. Le, and Vinayak K. Nahar have no conflicts of interest.
Free to read: This content has been made available to all.
